Compare PTGX & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | NXE |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.9B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | NXE |
|---|---|---|
| Price | $89.29 | $9.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $86.44 | N/A |
| AVG Volume (30 Days) | 886.1K | ★ 7.3M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $209,217,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $296.47 | N/A |
| P/E Ratio | $124.09 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $3.91 |
| 52 Week High | $93.25 | $9.99 |
| Indicator | PTGX | NXE |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 58.65 |
| Support Level | $83.52 | $8.86 |
| Resistance Level | $90.85 | $9.99 |
| Average True Range (ATR) | 2.63 | 0.48 |
| MACD | -0.33 | 0.18 |
| Stochastic Oscillator | 83.62 | 78.01 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.